Privium Fund Management (UK)’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-44,500
Closed -$676K 120
2022
Q1
$676K Buy
+44,500
New +$678K 0.38% 40

Other funds holding NPTN

Privium Fund Management (UK)'s NPTN Position: Q2 2022 in Review

Privium Fund Management (UK) sold out of NEOPHOTONICS CORP (NPTN) in Q2 2022, closing a stake of 44,500 shares — an estimated $676K sold.

Privium Fund Management (UK) first reported a position in NPTN in Q1 2022 and held it in 1 quarter. The position peaked at $676K in Q1 2022. 156 funds tracked by Wall St. Rank hold NPTN as of Q2 2022.

  • Privium Fund Management (UK) reported no remaining NEOPHOTONICS CORP position as of Q2 2022 after selling out during the quarter.
  • Privium Fund Management (UK) sold 44,500 NEOPHOTONICS CORP shares in Q2 2022, an estimated $676K.
  • Privium Fund Management (UK) first reported a position in NEOPHOTONICS CORP in Q1 2022 and held it in 1 quarter.
  • Privium Fund Management (UK)'s NEOPHOTONICS CORP position peaked at $676K in Q1 2022.
  • 156 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2022.

Based on Privium Fund Management (UK)'s 13F filing for Q2 2022, filed 28 Jul 2022.